-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation